...
首页> 外文期刊>Journal of biomedical materials research. Part B, Applied biomaterials. >Effects of added antibiotics on the basic properties of anti-washout-type fast-setting calcium phosphate cement.
【24h】

Effects of added antibiotics on the basic properties of anti-washout-type fast-setting calcium phosphate cement.

机译:添加的抗生素对抗冲洗型速凝磷酸钙水泥基本性能的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The effect of added antibiotics on the basic properties of anti-washout-type fast-setting calcium phosphate cement (aw-FSCPC) was investigated in a preliminary evaluation of aw-FSCPC containing drugs. Flomoxef sodium was employed as the antibiotic and was incorporated into the powder-phase aw-FSCPC at up to 10%. The setting time, consistency, wet diametral tensile strength (DTS) value, and porosity were measured for aw-FSCPC containing various amounts of flomoxef sodium. X-ray diffraction (XRD) analysis was also conducted for the identification of products. To evaluate the drug-release profile, set aw-FSCPC was immersed in saline and the released flomoxef sodium was determined at regular intervals. The spread area of the cement paste as an index of consistency of the cement increased progressively with the addition of flomoxef sodium, and it doubled when the aw-FSCPC contained 8% flomoxef sodium. In contrast, the wet DTS value decreased with increase in flomoxef sodium content. Bulk density measurement and scanning electron microscopic observation revealed that the set mass was more porous with the amount of flomoxef sodium contained in the aw-FSCPC. The XRD analysis revealed that formation of hydroxyapatite (HAP) from aw-FSCPC was reduced even after 24 h, when the aw-FSCPC contained flomoxef sodium at > or = 6%. Therefore, the decrease of wet DTS value was thought to be partly the result of the increased porosity and inhibition of HAP formation in aw-FSCPC containing large amounts of flomoxef sodium. The flomoxef sodium release from aw-FSCPC showed the typical profile observed in a skeleton-type drug delivery system (DDS). The rate of drug release from aw-FSCPC can be controlled by changing the concentration of sodium alginate. Although flomoxef sodium addition has certain disadvantageous effects on the basic properties of aw-FSCPC, we conclude that aw-FSCPC is a good candidate for potential use as a DDS carrier that may be useful in surgical operations.
机译:在对含aw-FSCPC药物的初步评估中,研究了添加的抗生素对抗冲洗型速凝磷酸钙水泥(aw-FSCPC)基本性能的影响。 Flomoxef钠用作抗生素,并以高达10%的比例掺入粉末相aw-FSCPC中。对于包含各种氟莫昔芬钠含量的aw-FSCPC,测量了凝固时间,稠度,湿直径抗拉强度(DTS)值和孔隙率。还进行了X射线衍射(XRD)分析以鉴定产物。为评估药物释放曲线,将aw-FSCPC浸入盐水中,并定期测定释放的氟莫昔芬钠含量。水泥浆的扩散面积作为水泥的稠度指标随氟莫昔钠的添加而逐渐增加,而当aw-FSCPC包含8%氟莫昔钠时,其扩散面积增加了一倍。相反,湿DTS值随氟莫昔钠含量的增加而降低。堆积密度测量和扫描电子显微镜观察表明,aw-FSCPC中所含氟莫昔钠的含量使设定质量更加多孔。 XRD分析表明,即使aw-FSCPC含有氟莫昔芬钠含量≥6%,甚至从24小时后,aw-FSCPC的羟基磷灰石(HAP)的形成量也减少了。因此,湿DTS值的降低被认为部分是孔隙率增加和在含有大量氟莫昔钠的aw-FSCPC中抑制HAP形成的结果。从aw-FSCPC释放的氟莫昔钠显示出在骨架型药物递送系统(DDS)中观察到的典型特征。可以通过改变藻酸钠的浓度来控制aw-FSCPC释放药物的速率。尽管氟莫昔钠的添加对aw-FSCPC的基本特性有某些不利影响,但我们得出的结论是aw-FSCPC是潜在用作DDS载体的良好候选者,在外科手术中可能有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号